0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metaproteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-5M19888
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Metaproteomics Service Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Metaproteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5M19888
Report
October 2025
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Metaproteomics Service Market Size

The global Metaproteomics Service market is projected to grow from US$ 185 million in 2024 to US$ 215 million by 2031, at a CAGR of 2.2% (2025-2031), driven by critical product segments and diverse end‑use applications.

Metaproteomics Service Market

Metaproteomics Service Market

Metaproteomics Service is a professional service for studying the proteome of complex microbial communities through mass spectrometry and bioinformatics technology. The service aims to comprehensively analyze the protein composition, expression level and function of microbial communities, revealing the metabolic activities and interactions of microorganisms in the environment, host or specific ecosystem. Unlike the proteomics of a single strain, Metaproteomics Service focuses on all proteins in a mixed population, helping researchers interpret the dynamic changes and functional networks of microbial communities.
From a downstream perspective, Biomedicine accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Metaproteomics Service leading manufacturers including Creative Proteomics, PolyQuant, BGI, CD Genomics, Westlakeomics, Mtoz Biolabs, Unipept, PTMBIO, BIO MIAO BIOLOGICAL, Biotech Pack, etc., dominate supply; the top five capture approximately % of global revenue, with Creative Proteomics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Metaproteomics Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Metaproteomics Service Market Report

Report Metric Details
Report Name Metaproteomics Service Market
Accounted market size in 2024 US$ 185 million
Forecasted market size in 2031 US$ 215 million
CAGR 2.2%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Sample Type:Feces
  • Sample Type:Gut Content
  • Sample Type:Fermentation Residue
  • Others
Segment by Application
  • Biomedicine
  • Clinical Diagnosis
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Proteomics, PolyQuant, BGI, CD Genomics, Westlakeomics, Mtoz Biolabs, Unipept, PTMBIO, BIO MIAO BIOLOGICAL, Biotech Pack
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Metaproteomics Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Metaproteomics Service Market growing?

Ans: The Metaproteomics Service Market witnessing a CAGR of 2.2% during the forecast period 2025-2031.

What is the Metaproteomics Service Market size in 2031?

Ans: The Metaproteomics Service Market size in 2031 will be US$ 215 million.

Who are the main players in the Metaproteomics Service Market report?

Ans: The main players in the Metaproteomics Service Market are Creative Proteomics, PolyQuant, BGI, CD Genomics, Westlakeomics, Mtoz Biolabs, Unipept, PTMBIO, BIO MIAO BIOLOGICAL, Biotech Pack

What are the Application segmentation covered in the Metaproteomics Service Market report?

Ans: The Applications covered in the Metaproteomics Service Market report are Biomedicine, Clinical Diagnosis, Others

What are the Type segmentation covered in the Metaproteomics Service Market report?

Ans: The Types covered in the Metaproteomics Service Market report are Sample Type:Feces, Sample Type:Gut Content, Sample Type:Fermentation Residue, Others

1 Study Coverage
1.1 Introduction to Metaproteomics Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Metaproteomics Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Sample Type:Feces
1.2.3 Sample Type:Gut Content
1.2.4 Sample Type:Fermentation Residue
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Metaproteomics Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Biomedicine
1.3.3 Clinical Diagnosis
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Metaproteomics Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Metaproteomics Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Metaproteomics Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Metaproteomics Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Sample Type:Feces Market Size by Players
3.3.2 Sample Type:Gut Content Market Size by Players
3.3.3 Sample Type:Fermentation Residue Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Metaproteomics Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Metaproteomics Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Metaproteomics Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Metaproteomics Service Market Size by Type (2020-2031)
6.4 North America Metaproteomics Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Metaproteomics Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Metaproteomics Service Market Size by Type (2020-2031)
7.4 Europe Metaproteomics Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Metaproteomics Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Metaproteomics Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Metaproteomics Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Metaproteomics Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Metaproteomics Service Market Size by Type (2020-2031)
9.4 Central and South America Metaproteomics Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Metaproteomics Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Metaproteomics Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Metaproteomics Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Metaproteomics Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Creative Proteomics
11.1.1 Creative Proteomics Corporation Information
11.1.2 Creative Proteomics Business Overview
11.1.3 Creative Proteomics Metaproteomics Service Product Features and Attributes
11.1.4 Creative Proteomics Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.1.5 Creative Proteomics Metaproteomics Service Revenue by Product in 2024
11.1.6 Creative Proteomics Metaproteomics Service Revenue by Application in 2024
11.1.7 Creative Proteomics Metaproteomics Service Revenue by Geographic Area in 2024
11.1.8 Creative Proteomics Metaproteomics Service SWOT Analysis
11.1.9 Creative Proteomics Recent Developments
11.2 PolyQuant
11.2.1 PolyQuant Corporation Information
11.2.2 PolyQuant Business Overview
11.2.3 PolyQuant Metaproteomics Service Product Features and Attributes
11.2.4 PolyQuant Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.2.5 PolyQuant Metaproteomics Service Revenue by Product in 2024
11.2.6 PolyQuant Metaproteomics Service Revenue by Application in 2024
11.2.7 PolyQuant Metaproteomics Service Revenue by Geographic Area in 2024
11.2.8 PolyQuant Metaproteomics Service SWOT Analysis
11.2.9 PolyQuant Recent Developments
11.3 BGI
11.3.1 BGI Corporation Information
11.3.2 BGI Business Overview
11.3.3 BGI Metaproteomics Service Product Features and Attributes
11.3.4 BGI Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.3.5 BGI Metaproteomics Service Revenue by Product in 2024
11.3.6 BGI Metaproteomics Service Revenue by Application in 2024
11.3.7 BGI Metaproteomics Service Revenue by Geographic Area in 2024
11.3.8 BGI Metaproteomics Service SWOT Analysis
11.3.9 BGI Recent Developments
11.4 CD Genomics
11.4.1 CD Genomics Corporation Information
11.4.2 CD Genomics Business Overview
11.4.3 CD Genomics Metaproteomics Service Product Features and Attributes
11.4.4 CD Genomics Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.4.5 CD Genomics Metaproteomics Service Revenue by Product in 2024
11.4.6 CD Genomics Metaproteomics Service Revenue by Application in 2024
11.4.7 CD Genomics Metaproteomics Service Revenue by Geographic Area in 2024
11.4.8 CD Genomics Metaproteomics Service SWOT Analysis
11.4.9 CD Genomics Recent Developments
11.5 Westlakeomics
11.5.1 Westlakeomics Corporation Information
11.5.2 Westlakeomics Business Overview
11.5.3 Westlakeomics Metaproteomics Service Product Features and Attributes
11.5.4 Westlakeomics Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.5.5 Westlakeomics Metaproteomics Service Revenue by Product in 2024
11.5.6 Westlakeomics Metaproteomics Service Revenue by Application in 2024
11.5.7 Westlakeomics Metaproteomics Service Revenue by Geographic Area in 2024
11.5.8 Westlakeomics Metaproteomics Service SWOT Analysis
11.5.9 Westlakeomics Recent Developments
11.6 Mtoz Biolabs
11.6.1 Mtoz Biolabs Corporation Information
11.6.2 Mtoz Biolabs Business Overview
11.6.3 Mtoz Biolabs Metaproteomics Service Product Features and Attributes
11.6.4 Mtoz Biolabs Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.6.5 Mtoz Biolabs Recent Developments
11.7 Unipept
11.7.1 Unipept Corporation Information
11.7.2 Unipept Business Overview
11.7.3 Unipept Metaproteomics Service Product Features and Attributes
11.7.4 Unipept Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.7.5 Unipept Recent Developments
11.8 PTMBIO
11.8.1 PTMBIO Corporation Information
11.8.2 PTMBIO Business Overview
11.8.3 PTMBIO Metaproteomics Service Product Features and Attributes
11.8.4 PTMBIO Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.8.5 PTMBIO Recent Developments
11.9 BIO MIAO BIOLOGICAL
11.9.1 BIO MIAO BIOLOGICAL Corporation Information
11.9.2 BIO MIAO BIOLOGICAL Business Overview
11.9.3 BIO MIAO BIOLOGICAL Metaproteomics Service Product Features and Attributes
11.9.4 BIO MIAO BIOLOGICAL Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.9.5 BIO MIAO BIOLOGICAL Recent Developments
11.10 Biotech Pack
11.10.1 Biotech Pack Corporation Information
11.10.2 Biotech Pack Business Overview
11.10.3 Biotech Pack Metaproteomics Service Product Features and Attributes
11.10.4 Biotech Pack Metaproteomics Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Metaproteomics ServiceIndustry Chain Analysis
12.1 Metaproteomics Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Metaproteomics Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Metaproteomics Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Metaproteomics Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Metaproteomics Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Metaproteomics Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Metaproteomics Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Metaproteomics Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Metaproteomics Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Metaproteomics Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Metaproteomics Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metaproteomics Service as of 2024)
 Table 11. Global Metaproteomics Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Metaproteomics Service Companies Headquarters
 Table 13. Global Metaproteomics Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Metaproteomics Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Metaproteomics Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Metaproteomics Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Metaproteomics Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Metaproteomics Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Metaproteomics Service Growth Accelerators and Market Barriers
 Table 25. North America Metaproteomics Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Metaproteomics Service Growth Accelerators and Market Barriers
 Table 27. Europe Metaproteomics Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Metaproteomics Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Metaproteomics Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Metaproteomics Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Metaproteomics Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Metaproteomics Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Metaproteomics Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Creative Proteomics Corporation Information
 Table 35. Creative Proteomics Description and Major Businesses
 Table 36. Creative Proteomics Product Features and Attributes
 Table 37. Creative Proteomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Creative Proteomics Revenue Proportion by Product in 2024
 Table 39. Creative Proteomics Revenue Proportion by Application in 2024
 Table 40. Creative Proteomics Revenue Proportion by Geographic Area in 2024
 Table 41. Creative Proteomics Metaproteomics Service SWOT Analysis
 Table 42. Creative Proteomics Recent Developments
 Table 43. PolyQuant Corporation Information
 Table 44. PolyQuant Description and Major Businesses
 Table 45. PolyQuant Product Features and Attributes
 Table 46. PolyQuant Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. PolyQuant Revenue Proportion by Product in 2024
 Table 48. PolyQuant Revenue Proportion by Application in 2024
 Table 49. PolyQuant Revenue Proportion by Geographic Area in 2024
 Table 50. PolyQuant Metaproteomics Service SWOT Analysis
 Table 51. PolyQuant Recent Developments
 Table 52. BGI Corporation Information
 Table 53. BGI Description and Major Businesses
 Table 54. BGI Product Features and Attributes
 Table 55. BGI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. BGI Revenue Proportion by Product in 2024
 Table 57. BGI Revenue Proportion by Application in 2024
 Table 58. BGI Revenue Proportion by Geographic Area in 2024
 Table 59. BGI Metaproteomics Service SWOT Analysis
 Table 60. BGI Recent Developments
 Table 61. CD Genomics Corporation Information
 Table 62. CD Genomics Description and Major Businesses
 Table 63. CD Genomics Product Features and Attributes
 Table 64. CD Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. CD Genomics Revenue Proportion by Product in 2024
 Table 66. CD Genomics Revenue Proportion by Application in 2024
 Table 67. CD Genomics Revenue Proportion by Geographic Area in 2024
 Table 68. CD Genomics Metaproteomics Service SWOT Analysis
 Table 69. CD Genomics Recent Developments
 Table 70. Westlakeomics Corporation Information
 Table 71. Westlakeomics Description and Major Businesses
 Table 72. Westlakeomics Product Features and Attributes
 Table 73. Westlakeomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Westlakeomics Revenue Proportion by Product in 2024
 Table 75. Westlakeomics Revenue Proportion by Application in 2024
 Table 76. Westlakeomics Revenue Proportion by Geographic Area in 2024
 Table 77. Westlakeomics Metaproteomics Service SWOT Analysis
 Table 78. Westlakeomics Recent Developments
 Table 79. Mtoz Biolabs Corporation Information
 Table 80. Mtoz Biolabs Description and Major Businesses
 Table 81. Mtoz Biolabs Product Features and Attributes
 Table 82. Mtoz Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Mtoz Biolabs Recent Developments
 Table 84. Unipept Corporation Information
 Table 85. Unipept Description and Major Businesses
 Table 86. Unipept Product Features and Attributes
 Table 87. Unipept Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Unipept Recent Developments
 Table 89. PTMBIO Corporation Information
 Table 90. PTMBIO Description and Major Businesses
 Table 91. PTMBIO Product Features and Attributes
 Table 92. PTMBIO Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. PTMBIO Recent Developments
 Table 94. BIO MIAO BIOLOGICAL Corporation Information
 Table 95. BIO MIAO BIOLOGICAL Description and Major Businesses
 Table 96. BIO MIAO BIOLOGICAL Product Features and Attributes
 Table 97. BIO MIAO BIOLOGICAL Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. BIO MIAO BIOLOGICAL Recent Developments
 Table 99. Biotech Pack Corporation Information
 Table 100. Biotech Pack Description and Major Businesses
 Table 101. Biotech Pack Product Features and Attributes
 Table 102. Biotech Pack Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Biotech Pack Recent Developments
 Table 104. Raw Materials Key Suppliers
 Table 105. Distributors List
 Table 106. Market Trends and Market Evolution
 Table 107. Market Drivers and Opportunities
 Table 108. Market Challenges, Risks, and Restraints
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources


List of Figures
 Figure 1. Metaproteomics Service Product Picture
 Figure 2. Global Metaproteomics Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Sample Type:Feces Product Picture
 Figure 4. Sample Type:Gut Content Product Picture
 Figure 5. Sample Type:Fermentation Residue Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Metaproteomics Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Biomedicine
 Figure 9. Clinical Diagnosis
 Figure 10. Others
 Figure 11. Metaproteomics Service Report Years Considered
 Figure 12. Global Metaproteomics Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Metaproteomics Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Metaproteomics Service Revenue Market Share by Region (2020-2031)
 Figure 16. Global Metaproteomics Service Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Sample Type:Feces Revenue Market Share by Player in 2024
 Figure 19. Sample Type:Gut Content Revenue Market Share by Player in 2024
 Figure 20. Sample Type:Fermentation Residue Revenue Market Share by Player in 2024
 Figure 21. Others Revenue Market Share by Player in 2024
 Figure 22. Global Metaproteomics Service Revenue Market Share by Type (2020-2031)
 Figure 23. Global Metaproteomics Service Revenue Market Share by Application (2020-2031)
 Figure 24. North America Metaproteomics Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. North America Top 5 Players Metaproteomics Service Revenue (US$ Million) in 2024
 Figure 26. North America Metaproteomics Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 27. North America Metaproteomics Service Revenue (US$ Million) by Application (2020-2031)
 Figure 28. US Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 29. Canada Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 30. Mexico Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 31. Europe Metaproteomics Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Europe Top 5 Players Metaproteomics Service Revenue (US$ Million) in 2024
 Figure 33. Europe Metaproteomics Service Revenue (US$ Million) by Type (2020-2031)
 Figure 34. Europe Metaproteomics Service Revenue (US$ Million) by Application (2020-2031)
 Figure 35. Germany Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 36. France Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 37. U.K. Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 38. Italy Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 39. Russia Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Metaproteomics Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Top 8 Players Metaproteomics Service Revenue (US$ Million) in 2024
 Figure 42. Asia-Pacific Metaproteomics Service Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Asia-Pacific Metaproteomics Service Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Indonesia Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 45. Japan Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 46. South Korea Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Australia Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 48. India Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Indonesia Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Vietnam Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Malaysia Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Philippines Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Singapore Metaproteomics Service Revenue (2020-2031) & (US$ Million)
 Figure 54. Central and South America Metaproteomics Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Central and South America Top 5 Players Metaproteomics Service Revenue (US$ Million) in 2024
 Figure 56. Central and South America Metaproteomics Service Revenue (US$ Million) by Type (2020-2031)
 Figure 57. Central and South America Metaproteomics Service Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Brazil Metaproteomics Service Revenue (2020-2025) & (US$ Million)
 Figure 59. Argentina Metaproteomics Service Revenue (2020-2025) & (US$ Million)
 Figure 60. Middle East and Africa Metaproteomics Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Middle East and Africa Top 5 Players Metaproteomics Service Revenue (US$ Million) in 2024
 Figure 62. South America Metaproteomics Service Revenue (US$ Million) by Type (2020-2031)
 Figure 63. Middle East and Africa Metaproteomics Service Revenue (US$ Million) by Application (2020-2031)
 Figure 64. GCC Countries Metaproteomics Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Israel Metaproteomics Service Revenue (2020-2025) & (US$ Million)
 Figure 66. Egypt Metaproteomics Service Revenue (2020-2025) & (US$ Million)
 Figure 67. South Africa Metaproteomics Service Revenue (2020-2025) & (US$ Million)
 Figure 68. Metaproteomics Service Industry Chain Mapping
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Metaproteomics Service Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-5M19888
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Artificial Intelligence in Biomedical Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-33S19787
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Pregelatinized Starch Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6P20101
Thu Oct 02 00:00:00 UTC 2025

Add to Cart

Global Bupivacaine Extended-Release Liposome Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-10L20096
Thu Oct 02 00:00:00 UTC 2025

Add to Cart